As shown in Fig. 5H–J, the recruitment of the dCas9-KRAB to interfere with LIMD1-AS1 SEs regions resulted in significant downregulation of LIMD1-AS1 expression in LN-18 and T98G glioma cells. This evidence concerns the gene LIMD1 and central nervous system cancer.